Inventor · disambiguated record
Robert Jennings
Also filed as: JENNINGS JR ROBERT N · JENNINGS ROBERT · JENNINGS ROBERT E · JENNINGS ROBERT N
9 granted patents·17 pending applications·286 citations·filing 1976–2025
90Inventor score
Top patents by PatentIndex Score
26 records- 0193US6187330B1Controlled release delivery of peptide or proteinSCIOS INC·Filed 1999·Granted Feb 13, 2001·125 cites·36 claims
- 0287US8008255B2Methods and compositions for enhanced transmucosal delivery of peptides and proteinsAMYLIN PHARMACEUTICALS INC·Filed 2004·Granted Aug 30, 2011·18 cites·8 claims
- 0383US8895033B2Sustained release formulations using non-aqueous carriersHOUCHIN MARY L·Filed 2009·Granted Nov 25, 2014·15 cites·18 claims
- 0482US6331309B1Hydrogel compositions for the controlled release administration of growth factorsSCIOS INC·Filed 1999·Granted Dec 18, 2001·53 cites·37 claims
- 0581US7848019B2Microscope calibration apparatus and method and stage including calibration apparatusCYTYC CORP·Filed 2007·Granted Dec 7, 2010·11 cites·22 claims
- 0675US4062576ASliding glass window and door lockJENNINGS ROBERT NEWTON·Filed 1976·Granted Dec 13, 1977·33 cites·14 claims
- 0773US6322277B1Clamp for interconnecting components of shoring apparatusWILIAN HOLDING CO·Filed 2000·Granted Nov 27, 2001·18 cites·9 claims
- 0869US2009291886A1Transmucosal delivery of peptides and proteinsAMYLIN PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 0968US11977215B2Digital imaging system and methodHOLOGIC INC·Filed 2019·Granted May 7, 2024·0 cites·19 claims
- 1068US2015111824A1Pharmaceutical Formulations Comprising Incretin Mimetic Peptide and Aprotic Polar SolventAMYLIN PHARMACEUTICALS LLC·Filed 2014·Application pending·0 cites
- 1166US2025159394A1Digital imaging system and methodHOLOGIC INC·Filed 2025·Application pending·0 cites
- 1264US2008200383A1Pharmaceutical Formulations Comprising Incretin Peptide and Aprotic Polar SolventAMYLIN PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1363US2015157725A1Transmucosal delivery of peptides and proteinsAMYLIN PHARMACEUTICALS LLC·Filed 2014·Application pending·0 cites
- 1462US2020405815A1Sustained release formulations using non-aqueous carriersAMYLIN PHARMACEUTICALS LLC·Filed 2020·Application pending·0 cites
- 1558US2005215475A1Transmucosal delivery of peptides and proteinsONG JOHN·Filed 2005·Application pending·0 cites
- 1657US2015056285A1Sustained release formulations using non-aqueous carriersAMYLIN PHARMACEUTICALS LLC·Filed 2014·Application pending·0 cites
- 1756US2009069226A1Transmucosal delivery of peptides and proteinsAMYLIN PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 1855US2018271946A1Sustained release formulations using non-aqueous carriersAMYLIN PHARMACEUTICALS LLC·Filed 2018·Application pending·0 cites
- 1952US4300795ASliding glass window and door lock apparatus including lock unit with dual spring biased eccentricsJENNINGS ROBERT N·Filed 1979·Granted Nov 17, 1981·13 cites·1 claims
- 2052US2014093552A1Multilayer Biodegradable Microparticles for Sustained Release of Therapeutic AgentsSKS OCULAR LLC·Filed 2013·Application pending·0 cites
- 2151US2016346357A1Sustained release formulations using non-aqueous carriersAMYLIN PHARMACEUTICALS LLC·Filed 2016·Application pending·0 cites
- 2249US2017354611A1Multilayer Biodegradable Microparticles for Sustained Release of Therapeutic AgentsOHR PHARMA LLC·Filed 2017·Application pending·0 cites
- 2348US2016120950A1Pharmaceutical Formulations Comprising Incretin Mimetic Peptide and Aprotic Polar SolventAMYLIN PHARMACEUTICALS LLC·Filed 2015·Application pending·0 cites
- 2447US2004101628A1Non-spray invisible small area repair techniqueFiled 2002·Application pending·0 cites
- 2546US2010168011A1Pharmaceutical Formulations and Methods for Making the SameAMYLIN PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 2639US2021233647A1Digital imaging system and methodHOLOGIC INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robert Jennings files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →